Results 91 to 100 of about 16,276 (198)

Comparison of P2Y12 inhibitors for mortality and stent thrombosis in patients with acute coronary syndromes: Single center study of 10 793 consecutive ‘real-world’ patients

Platelets, 2017
Three oral platelet P2Y12 inhibitors, clopidogrel, prasugrel, and ticagrelor, are available for reducing the risk of cardiovascular death and stent thrombosis in patients with acute coronary syndromes (ACS).
Rebecca Gosling, Momina Yazdani, Yasir Parviz, Ian R Hall, Ever D. Grech, Julian P Gunn, Robert F. Storey, Javaid Iqbal   +7 more
doaj   +1 more source

PCI in patients with atrial fibrillation - triple therapy with aspirin, clopidogrel and VKA, a single center experience [PDF]

, 2013
M. Kaiser, Christoph Hehrlein, Christoph Bode, Ingo Ahrens   +3 more
openalex   +1 more source

A Comparative Study of Ticagrelor and Clopidogrel in Patients Undergoing Elective Coronary Stenting

, 2023
Umer Farooq, Hira Anum, Muhammad Nabeel Akhtar, Ejaz Ul Haq, Khadija Sarwat Farooqui, Ifrah Uroos   +5 more
openalex   +2 more sources

Rethinking Statin Dosage in Coronary Disease

Pharmacology Research &Perspectives, Volume 14, Issue 1, February 2026.
It is widely acknowledged that a sufficient statin dose is important in the management of symptomatic coronary disease, along with weight reduction and appropriate antithrombotic, blood pressure, and diabetes pharmacotherapy. Mid‐range statin doses have been shown to achieve the maximum improvements in total mortality and have the advantage of greater ...
Simon B. Dimmitt, Hans G. Stampfer, Michael C. Kennedy, Jennifer H. Martin   +3 more
wiley   +1 more source

Clopidogrel resistance and its relevance: Current concepts

Journal of Family Medicine and Primary Care
Clopidogrel is the most widely used P2Y12 receptor inhibitor (P2Y12i) as a part of dual antiplatelet therapy along with aspirin. Clopidogrel is a pro-drug and is metabolized to its active metabolite by the hepatic enzyme cytochrome P4502C19 (CYP2C19 ...
Akshyaya Pradhan, Monika Bhandari, Pravesh Vishwakarma, Rishi Sethi   +3 more
doaj   +1 more source

Comparison of the antiplatelet effect of clopidogrel hydrogeno sulfate and clopidogrel besylate in patients with stable coronary artery disease [PDF]

, 2013
M. C. Chamilos, I. Saloustros, GE Kochiadakis, E. S. Skalidis, N. I. Igoumenidis, D. Vougia, I. L. Logkakis, P. Vardas   +7 more
openalex   +1 more source

High Rates of Defect Closure After Resection of Large Nonpedunculated Colorectal Lesions Using a Through‐The‐Scope Clip With Anchor Prongs

United European Gastroenterology Journal, Volume 14, Issue 1, February 2026.
ABSTRACT Background Prophylactic complete closure of mucosal defects after resection of gastrointestinal lesions is key to reducing delayed bleeding, but complete closure for large defects can be challenging with conventional through‐the‐scope clips (TTSC).
Daniel von Renteln, Douglas K. Rex, Heiko Pohl, Nikhil A. Kumta, Shannon Chan, Marvin Ryou, Zaheer Nabi, Ping Hong Zhou, Haruhiro Inoue, Joyce A. Peetermans, Matthew J. Rousseau, Jeffrey D. Mosko   +11 more
wiley   +1 more source

Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapy

Therapeutics and Clinical Risk Management, 2015
Zhi-Yu Wang,1 Meng Chen,1 Ling-Ling Zhu,2 Lu-Shan Yu,3 Su Zeng,3 Mei-Xiang Xiang,4 Quan Zhou1 1Department of Pharmacy, 2VIP Care Ward, Division of Nursing, the Second Affiliated Hospital, School of Medicine, 3Department of Pharmaceutical Analysis and ...
Wang ZY, Chen M, Zhu LL, Yu LS, Zeng S, Xiang MX, Zhou Q   +6 more
doaj  

Clopidogrel resistance in patients with ST-elevation myocardial infarction is associated with high body mass index [PDF]

, 2013
Ingebjørg Seljeflot, Geir Øystein Andersen, Sigrun Halvorsen, Reidar Bjørnerheim, Jan Eritsland, Harald Arnesen   +5 more
openalex   +1 more source

A Multicenter Prospective Cohort Study on the Use of Weight‐Adjusted Dalteparin in Patients Over 90 kg With Acute Cancer‐Associated Venous Thromboembolism—The WAVe Study

American Journal of Hematology, Volume 101, Issue 1, Page 79-88, January 2026.
The WAVe stdudy‐ A multicenter prospective cohort study of wieght‐adjusted dalteparin in patients over 90 kg with acute cancer‐associated venous thromboembolism. ABSTRACT Patients with cancer‐associated thrombosis (CAT) are commonly treated with low‐molecular‐weight heparin (LMWH), but whether dose capping is needed in patients over 90 kg is unclear ...
Tzu‐Fei Wang, Erik Yeo, Peter L. Gross, Chantal Séguin, Cynthia Wu, Sudeep Shivakumar, Ranjeeta Mallick, Aurélien Delluc, Julien D'Astous, Miriam Kimpton, Guillaume Roberge, Deborah M. Siegal, Tobias Tritschler, Grégoire Le Gal, Marc Carrier   +14 more
wiley   +1 more source